ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.663,83
-0,52%
S&P 500
5.304,74
0,00%
Dow Jones
38.919,90
-0,38%
Euro vs US Dollar
1,08743
0,12%
Bitcoin
67.858,26
-2,21%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. scPharmaceuticals Inc (SCPH)

  7. scPharmaceuticals Inc (SCPH) News

SCPH

scPharmaceuticals (SCPH)

scPharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SCPH
DatumZeitQuelleÜberschriftSymbolFirma
16/05/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCPHscPharmaceuticals Inc
14/05/202422h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCPHscPharmaceuticals Inc
14/05/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCPHscPharmaceuticals Inc
02/02/202418h35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCPHscPharmaceuticals Inc
23/01/202402h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SCPHscPharmaceuticals Inc
04/01/202423h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCPHscPharmaceuticals Inc
03/01/202422h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SCPHscPharmaceuticals Inc
08/11/202322h23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCPHscPharmaceuticals Inc
08/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCPHscPharmaceuticals Inc
20/09/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCPHscPharmaceuticals Inc
10/08/202322h14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCPHscPharmaceuticals Inc
10/08/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCPHscPharmaceuticals Inc
08/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPHscPharmaceuticals Inc
08/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPHscPharmaceuticals Inc
08/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPHscPharmaceuticals Inc
08/06/202322h16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPHscPharmaceuticals Inc
08/06/202322h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPHscPharmaceuticals Inc
07/06/202313h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPHscPharmaceuticals Inc
10/05/202322h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPHscPharmaceuticals Inc
27/04/202322h28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCPHscPharmaceuticals Inc
27/04/202322h25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SCPHscPharmaceuticals Inc
22/03/202322h16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SCPHscPharmaceuticals Inc
22/03/202321h31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPHscPharmaceuticals Inc
13/03/202321h45Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCPHscPharmaceuticals Inc
10/03/202318h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPHscPharmaceuticals Inc
27/02/202316h07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCPHscPharmaceuticals Inc
14/02/202322h08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCPHscPharmaceuticals Inc
14/02/202319h26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCPHscPharmaceuticals Inc
23/01/202323h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPHscPharmaceuticals Inc
19/12/202222h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPHscPharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SCPH

Kürzlich von Ihnen besucht

BMF
DAFQ26Q28
DAFQ26Q28 - 08/2026
BIT
F18995
Vontobel Financial Produ...
COIN
UISBTC
HITB
WLKUSD
WOLK TOKEN
USOTC
CCHBF
Coca Cola HBC (PK)
EU
SNCBO
Societe Nationale SNCF S...
EU
SUBD
Schneider Electric SE Bo...
BOV
P2NB34Q
Penumbra
BIT
UB6KS2
Unicredit Bank
USOTC
TZROP
Tzero (GM)
TG
AN3
Alten
COIN
PNTEUR
pNetwork Token
LSE
0RA5
Electro Power Systems
EU
SGHJ
Societe Generale SA Nts ...
BIT
F18106
Vontobel Financial Produ...
EU
BE2615843445
Euronext VPU Public auct...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten